Drug Type Oligonucleotide |
Synonyms SNK 396, SNK396 |
Target |
Action antagonists |
Mechanism GaINAc antagonists(N-Acetylgalactosamine antagonists) |
Therapeutic Areas- |
Active Indication- |
Inactive Indication- |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingPhase 1 |
First Approval Date- |
Regulation- |






